What is BrightInsight?
BrightInsight offers a leading global platform for biopharma and medtech regulated digital health solutions, encompassing Software as a Medical Device (SaMD), data insights, and disease management tools. The company empowers top life sciences firms to build, scale, and optimize digital health offerings that enhance patient care across diverse therapeutic areas. BrightInsight's platform is instrumental in developing companion apps and connected products, fundamentally transforming patient experiences within the healthcare ecosystem. Their focus on delivering tangible business and clinical returns has attracted a clientele that includes many of the industry's leading pharmaceutical corporations.
How much funding has BrightInsight raised?
BrightInsight has raised a total of $179M across 4 funding rounds:
Series A
$25M
Series B
$40M
Series C
$101M
Unspecified
$13M
Series A (2019): $25M with participation from Eclipse Ventures and New Leaf Venture Partners
Series B (2020): $40M led by New Leaf Venture Partners, Insight Partners, and Eclipse
Series C (2021): $101M supported by General Catalyst Partners, New Leaf Venture Partners, Insight Partners, and Eclipse Ventures Incorporated
Unspecified (2026): $13M featuring Mayo Clinic, Insight Partners, New Leaf Venture Partners, and General Catalyst
Key Investors in BrightInsight
Mayo Clinic
Mayo Clinic is a globally recognized nonprofit healthcare organization renowned for its integrated clinical practice, education, and medical research, contributing to advancements in healthcare innovation.
Insight Partners
Insight Partners is a global venture capital and private equity firm specializing in high-growth software and technology companies, providing capital and operational support for scaling businesses.
New Leaf Venture Partners
New Leaf Venture Partners is a venture capital firm dedicated to funding innovative companies within the healthcare sector, aiming to support transformative technologies that improve patient care and health outcomes.
What's next for BrightInsight?
With its latest major strategic investment, BrightInsight is poised to accelerate its growth and further solidify its market leadership. The company's trajectory, marked by consistent funding rounds from Series A through Series C and now a significant recent investment, indicates a strong market demand for its regulated digital health solutions. Future developments will likely focus on expanding its platform capabilities, deepening its integration with biopharma and medtech partners, and potentially exploring new therapeutic areas or geographical markets. The substantial backing suggests a strategic push towards scaling operations and enhancing its competitive edge in the rapidly evolving digital health landscape.
See full BrightInsight company page
